Quantification of plasmid copy number as surrogate marker of virulence among different invasive and non-invasive genotypes of Chlamydia trachomatis

Diagn Microbiol Infect Dis. 2022 Apr;102(4):115610. doi: 10.1016/j.diagmicrobio.2021.115610. Epub 2021 Nov 28.

Abstract

The population dissemination of invasive genotypes of C. trachomatis and an increase of urogenital infections cases by non-invasive genotypes have been observed in many countries. In this epidemiological context, the descriptions of a high proportion of infections related to L-genotypes in asymptomatic patients, but also to infections caused by non-L genotypes in symptomatic patients have been unexpected finding. The plasmid copy number (PCN) has been proposed as a surrogate marker of virulence. We quantified the PCN in 233 samples and 179 samples carrying L-genotype and non-L genotypes respectively. A significant difference in the median of PCN was detected between symptomatic/asymptomatic patients (P < 0.001), independently of the genotype. Moreover, PCN could vary, in the same strain, among different anatomical sites suggesting that micro-environmental changes could affect virulence. These findings suggest that the quantification of PCN in clinical samples could improve the management of patients.

Keywords: Chlamydia trachomatis; Lymphogranuloma venereum; Plasmid copy number; Virulence factors.

MeSH terms

  • Biomarkers
  • Chlamydia Infections* / epidemiology
  • Chlamydia trachomatis / genetics
  • DNA Copy Number Variations
  • Genotype
  • Humans
  • Lymphogranuloma Venereum*
  • Plasmids / genetics
  • Virulence / genetics

Substances

  • Biomarkers